プロテインチップ - 市場考察、競合情勢、市場予測（2030年）

世界のプロテインチップの市場規模は、2024年～2030年の予測期間にCAGRで6.73％の成長が見込まれます。がん、糖尿病、心血管障害などの慢性疾患の有病率の増加は、これらの疾患をよりよく理解し、新治療法を開発するための研究開発活動が高まっていることから、プロテインチップ市場を牽引します。さらに、さまざまな臨床研究においてプロテインチップが提供するさまざまな用途も、2024年～2030年の予測期間に市場成長を促進する要因となっています。

プロテインチップの市場力学

Global Cancer Observatoryが提供した最新データによると、2022年に世界で新たに発生したがん患者数は2,000万人と推定され、2045年までに3,260万人に増加すると予測されています。また、同データによると、欧州における新規がん患者数は447万人で、2045年までに548万人に増加すると予測されています。さらに、British Heart Foundation（2024年）が提供した近年のデータによると、2021年に世界全体で約6億2,000万人が心血管疾患を患っていました。

さらに、International Diabetes Federationが提供した近年のデータによると、2021年に約5億3,700万人の成人（20～79歳）が糖尿病を患っていました。糖尿病患者の総数は、2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。

したがって、がん、糖尿病、心血管疾患のような慢性疾患の有病率の増加は、主に医療研究開発での使用の増加により、プロテインチップの市場を大幅に強化します。多数のタンパク質を同時に分析できるプロテインチップは、研究者が分子レベルで疾病メカニズムを研究するための強力なツールとなります。これにより、新規バイオマーカーの同定が容易になり、早期診断や標的療法の開発が可能になります。さらに、ハイスループットスクリーニングを行うプロテインチップの能力は、創薬と研究開発のプロセスを加速し、研究者が新薬候補の有効性と安全性を迅速に評価することを可能にするため、プロテインチップの市場を押し上げます。

しかし、質数量分析、次世代シーケンシング、ウェスタンブロッティングなどの代替技術の使用や、タンパク質の相互作用の複雑性が、プロテインチップ市場の成長に若干の障害をもたらす可能性があります。

プロテインチップ市場のセグメント分析

プロテインチップ市場の用途セグメントでは、ゲノミクス・プロテオミクスカテゴリが2023年にプロテインチップ市場で大きな収益シェアを占めると推定されています。ゲノミクス・プロテオミクス用途は、プロテインバイオチップ市場の成長と優位性の促進に役立っています。ゲノミクスは、疾病に関連する遺伝子変異の同定を可能にし、個別化治療の開発やバイオマーカーの発見を先導します。一方、プロテオミクスは、タンパク質の発現、構造、機能に関する知見を提供し、疾病メカニズムや創薬ターゲットの理解に不可欠です。ハイスループットタンパク質分析を可能にするプロテインバイオチップは、複数のタンパク質の迅速かつ同時検出を可能にすることで、ともにゲノミクス・プロテオミクスの研究に不可欠となっています。この統合は診断精度を高め、創薬を促進し、個別化医療活動をサポートします。

この成長は、プロテオミクスとゲノミクスの応用分野におけるプロテインバイオチップ技術の継続的な進歩や共同研究によってさらに推進され、疾病診断をより迅速で、より信頼性が高く、より利用しやすくすることで、世界中の臨床現場や研究室での採用が広がっています。例えば2022年9月、Illumina Inc.はNovaSeq Xシリーズを発売し、より高速で強力な持続可能なシーケンシングを可能にしました。画期的な新技術であるNovaSeq X Plusは、年間に2万を超える全ゲノムを生成できるため、ゲノム探索と臨床考察を加速し、患者の生活を一変させます。このように、世界中でのこれらの発展が、地域のバイオチップ市場の成長を促進しています。その結果、プロテインバイオチップの需要は増加し、研究と臨床環境の両方で市場成長と採用が促進されると予測されます。

したがって、上記の要因に基づき、ゲノミクス・プロテオミクスカテゴリは大きな成長を示すと予測されます。この成長が予測期間のプロテインチップ市場全体を牽引します。

当レポートでは、世界のプロテインチップ市場について調査分析し、各地域の市場規模と予測、過去3年間の製品/技術開発、各セグメントの業績と見通しなどの情報を提供しています。

目次

第1章 プロテインチップ市場レポートのイントロダクション

第2章 プロテインチップ市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 プロテインチップ市場の主な要因の分析

• プロテインチップ市場の促進要因
• プロテインチップ市場の抑制要因と課題
• プロテインチップ市場の機会

第6章 プロテインチップ市場のポーターのファイブフォース分析

第7章 プロテインチップ市場の評価

• 技術別
  • 分析用タンパク質マイクロアレイ
  • 機能性タンパク質マイクロアレイ
  • 逆相タンパク質アレイ
• 用途別
  • ゲノミクス・プロテオミクス
  • 創薬
  • 抗体特性評価
• エンドユーザー別
  • 製薬企業、バイオテクノロジー企業
  • 学術、研究機関
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 プロテインチップ市場の企業と製品のプロファイル

• Agilent Technologies, Inc.
• RayBiotech, Inc.
• Sengenics Corporation LLC.
• CDI Labs.
• Creative Biolabs
• Proteintech Group, Inc
• RayBiotech Life Inc.
• QUOTIENT LIMITED
• PerkinElmer Inc.
• Merck KGAA
• Illmina Inc.
• Arrayit Corporation
• Spectrum Solutions
• ACROBiosystems
• Sengenics Corporation LLC

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Protein Chips Market in Global (2021-2030)
• Table 3: Protein Chips Market in Global by Technology (2021-2030)
• Table 4: Protein Chips Market in Global by Application (2021-2030)
• Table 5: Protein Chips Market in Global by End-user (2021-2030)
• Table 6: Protein Chips Market in Global by Geography (2021-2030)
• Table 7: Protein Chips Market in North America (2021-2030)
• Table 8: Protein Chips Market in the United States (2021-2030)
• Table 9: Protein Chips Market in Canada (2021-2030)
• Table 10: Protein Chips Market in Mexico (2021-2030)
• Table 11: Protein Chips Market in Europe (2021-2030)
• Table 12: Protein Chips Market in France (2021-2030)
• Table 13: Protein Chips Market in Germany (2021-2030)
• Table 14: Protein Chips Market in United Kingdom (2021-2030)
• Table 15: Protein Chips Market in Italy (2021-2030)
• Table 16: Protein Chips Market in Spain (2021-2030)
• Table 17: Protein Chips Market in the Rest of Europe (2021-2030)
• Table 18: Protein Chips Market in Asia-Pacific (2021-2030)
• Table 19: Protein Chips Market in China (2021-2030)
• Table 20: Protein Chips Market in Japan (2021-2030)
• Table 21: Protein Chips Market in India (2021-2030)
• Table 22: Protein Chips Market in Australia (2021-2030)
• Table 23: Protein Chips Market in South Korea (2021-2030)
• Table 24: Protein Chips Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Protein Chips Market in the Rest of the World (2021-2030)
• Table 26: Protein Chips Market in the Middle East (2021-2030)
• Table 27: Protein Chips Market in Africa (2021-2030)
• Table 28: Protein Chips Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Protein Chips Market in Global (2021-2030)
• Figure 3: Protein Chips Market in Global by Technology (2021-2030)
• Figure 4: Protein Chips Market in Global by Application (2021-2030)
• Figure 5: Protein Chips Market in Global by End-user (2021-2030)
• Figure 6: Protein Chips Market in Global by Geography (2021-2030)
• Figure 7: Protein Chips Market in North America (2021-2030)
• Figure 8: Protein Chips Market in the United States (2021-2030)
• Figure 9: Protein Chips Market in Canada (2021-2030)
• Figure 10: Protein Chips Market in Mexico (2021-2030)
• Figure 11: Protein Chips Market in Europe (2021-2030)
• Figure 12: Protein Chips Market in France (2021-2030)
• Figure 13: Protein Chips Market in Germany (2021-2030)
• Figure 14: Protein Chips Market in United Kingdom (2021-2030)
• Figure 17: Protein Chips Market in Italy (2021-2030)
• Figure 15: Protein Chips Market in Spain (2021-2030)
• Figure 16: Protein Chips Market in the Rest of Europe (2021-2030)
• Figure 17: Protein Chips Market in Asia-Pacific (2021-2030)
• Figure 18: Protein Chips Market in China (2021-2030)
• Figure 19: Protein Chips Market in Japan (2021-2030)
• Figure 20: Protein Chips Market in India (2021-2030)
• Figure 21: Protein Chips Market in Australia (2021-2030)
• Figure 22: Protein Chips Market in South Korea (2021-2030)
• Figure 23: Protein Chips Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Protein Chips Market in the Rest of the World (2021-2030)
• Figure 25: Protein Chips Market in the Middle East (2021-2030)
• Figure 26: Protein Chips Market in Africa (2021-2030)
• Figure 27: Protein Chips Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

Protein Chips Market By Technology (Analytical Protein Microarrays, Functional Protein Microarrays, And Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, And Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies, And Academic & Research Institutions), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of chronic disorders, growing applications of protein biochips in various clinical research studies

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders will drive the market for protein chips as there is a growing research and development efforts to understand these diseases better and develop new treatments. Additionally, various applications provided by protein chips in various clinical research studies, is another contributing factor propelling the market growth during the forecast period from 2024 to 2030.

Protein Chips Market Dynamics

According to the latest data provided by the Global Cancer Observatory, in 2022, the estimated number of new cancer cases globally was 20 million, with projections indicating a rise to 32.6 million cases by 2045. Additionally, as per the same source the new cases of cancer in Europe was 4.47 million, with projection estimating a rise to 5.48 million cases by 2045. Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 620 million people living with cardiovascular disease globally.

Furthermore, as per the recent data provided by the International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) were living with diabetes. The total number of people living with diabetes was projected to rise to 643 million by 2030 and 783 million by 2045.

Therefore, the growing prevalence of chronic conditions like cancer, diabetes, and cardiovascular diseases considerably enhances the market for protein chips, mainly due to their increasing usage in healthcare research and development. Protein chips, with their capability to analyze numerous proteins simultaneously, provide a powerful tool for researchers to study disease mechanisms at a molecular level. This facilitates the identification of novel biomarkers, enabling early diagnosis and the development of targeted therapies. Furthermore, the ability of protein chips to conduct high-throughput screenings accelerates drug discovery and development processes, allowing researchers to quickly assess the efficacy and safety of new drug candidates thereby boosting the market of protein chips.

However, the use of alternative technologies such as mass spectroscopy, next generation sequencing, western blotting, and complexity in protein interaction may result in slight obstacle to the growth of protein chips market.

Protein Chips Market Segment Analysis:

Protein Chips Market by Technology (Analytical Protein Microarrays, Functional Protein Microarrays, and Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, and Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies and Academic & Research Institutions), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the protein chip market, the genomics and proteomics category is estimated to mass a significant revenue share in the protein chips market in 2023. The application of genomics and proteomics has been instrumental in driving the growth and dominance of the protein biochip market. Genomics enables the identification of genetic variations associated with diseases, guiding the development of personalized therapies and the discovery of biomarkers. Proteomics, on the other hand, provides insights into the expression, structure, and function of proteins, crucial for understanding disease mechanisms and drug targets. Protein biochips, which allow for high-throughput protein analysis, are integral to both genomics and proteomics research by enabling rapid and simultaneous detection of multiple proteins. This integration enhances diagnostic accuracy, facilitates drug discovery, and supports personalized medicine initiatives, thereby expanding the protein biochip market significantly.

The growth is further propelled by ongoing advancements and collaborations in protein biochip technology in the field of proteomics and genomics applications, making disease diagnosis faster, more reliable, and more accessible, thereby broadening their adoption in clinical settings and research laboratories worldwide. For instance, In September 2022, Illumina Inc. launched the NovaSeq X Series, enabling faster and more powerful sustainable sequencing. The revolutionary new technology, NovaSeq X Plus could generate 20,000+ whole genomes per year, therefore accelerating genomic discovery and clinical insights to transform patient lives. Thus, such developments across the globe are driving the growth of the biochips market in the region. As a result, the demand for protein biochips is expected to increase, driving market growth and adoption in both research and clinical settings.

Accordingly, based on the factors mentioned above, the genomics and proteomics category is expected to experience significant growth. This growth will drive the overall protein chips market during the forecast period.

North America Is Expected To Dominate The Overall Protein Chips Market:

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.

According to recent data from the GLOBOCAN, in 2022, North America saw an estimated 2.67 million new cases of cancer, with forecasts indicating a rise to 3.83 million by 2045. As per the same source, in Canada, the number of new cancer cases was around 292,000 in 2022, projected to reach 449,000 by 2045. Meanwhile, in Mexico, there were approximately 207,000 new cases of cancer in 2022, expected to increase to 360,000 by 2045.

Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 48 million people living with cardiovascular disease in North America.

According to the latest report provided by the Centre of Disease Control and Prevention, in 2021 estimates indicated that 38.4 million people of all ages, or 11.6% of the U.S. population, had diabetes. Additionally 38.1 million individuals aged 18 years and older, representing 14.7% of all U.S. adults, were affected by diabetes in 2021.

As the surge of chronic disorders increases there is a significant increase in the research and development efforts to understand these diseases better and develop new treatments. Protein chips are crucial in this research as they allow for high-throughput analysis of protein interactions and functions, accelerating discoveries and innovations.

The growth is further propelled by ongoing acquisitions among the companies in protein biochip technology. For instance, in March 2023, Spectrum Solutions(R) acquired Alimetrix, Inc., a lab accredited by CLIA and CAP that specializes in creating custom diagnostic tests, and Microarrays, Inc., a company known for its array-based biological research tools like gene expression and protein arrays. Thus, this expanded product portfolio will cater to a wider range of applications in both biological research and clinical diagnostics, thereby increasing market reach.

Thus, the above mentioned factors are expected to escalate the market of protein chips in North America during the forecast years.

Protein Chips Market Key Players:

Some of the key market players operating in the Protein Chips market include Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

Recent Developmental Activities In The Protein Chips Market:

• In January 2024, Agilent Technologies launched the ProteoAnalyzer system, an advanced automated system for protein analysis using parallel capillary electrophoresis. This new platform makes it easier and more efficient to analyze complex protein mixtures. It is useful in various fields, including pharmaceuticals, biotechnology, food analysis, and academic research.
• In December 2023, Theralink Technologies announced groundbreaking research by George Mason University and the University of California, San Francisco, published in Cell Reports Medicine. The study used Theralink's RPPA (reverse phase protein array) technology to analyze tumors from over 700 breast cancer patients. It discovered a protein biomarker called HARPS, which can help better treat Triple Negative Breast Cancer (TNBC) by identifying appropriate therapies, leading to an 80% response rate compared to the current 30-40%.

Key Takeaways From The Protein Chips Market Report Study

• Market size analysis for current protein chips size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the protein chips market.
• Various opportunities available for the other competitors in the protein chips market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current protein chips market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for protein chips market growth in the coming future?

Target Audience Who Can Be Benefited From This Protein Chips Market Report Study

• Protein chips product providers
• Research organizations and consulting companies
• Protein chips -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in protein chips
• Various end-users who want to know more about the protein chips market and the latest technological developments in the protein chips market.

Frequently Asked Questions For The Protein Chips Market:

1. What are protein chips?

Protein chips, also known as protein microarrays, are sophisticated laboratory tools designed to study a vast array of proteins simultaneously. These chips consist of a solid surface, typically a glass slide or membrane, onto which thousands of different proteins are immobilized. They facilitate the high-throughput analysis of protein expression, interactions, activities, and functions, making them invaluable in various fields such as biomarker discovery, drug development, disease diagnostics, and functional proteomics.

2. What is the market for Protein Chips?

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the protein chips market?

The demand for protein chips is primarily being boosted by the growing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders. Additionally, growing applications of protein biochips in various clinical research studies is another major driver for the growth of the protein chips market during the forecast years.

4. Who are the key players operating in the protein chips market?

Some of the key market players operating in the protein chips are Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

5. Which region has the highest share in the protein chips market?

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.

Table of Contents

1. Protein Chips Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Protein Chips Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Protein Chips Market Key Factors Analysis

• 5.1. Protein Chips Market Drivers
  • 5.1.1. Growing prevalence of chronic disease
  • 5.1.2. Growing applications of protein biochips in various clinical research studies
• 5.2. Protein Chips Market Restraints and Challenges
  • 5.2.1. The use of alternative technologies
  • 5.2.2. Complexity in protein interaction
• 5.3. Protein Chips Market Opportunities
  • 5.3.1. Ongoing research & developmental activities pharmaceuticals for the treatment of chronic diseases

6. Protein Chips Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Protein Chips Market Assessment

• 7.1. By Technology
  • 7.1.1. Analytical Protein Microarrays
  • 7.1.2. Functional Protein Microarrays
  • 7.1.3. Reverse-Phase Protein Arrays
• 7.2. By Application
  • 7.2.1. Genomics & Proteomics
  • 7.2.2. Drug Discovery
  • 7.2.3. Antibody Characterization
• 7.3. By End-user
  • 7.3.1. Pharmaceutical and Biotechnology Companies
  • 7.3.2. Academic and Research Institutions
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.1.2. Canada Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.1.3. Mexico Protein Chips Market Size in USD Million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2.2. Germany Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2.3. United Kingdom Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2.4. Italy Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2.5. Spain Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2.6. Rest of Europe Protein Chips Market Size in USD Million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3.2. Japan Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3.3. India Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3.4. Australia Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3.5. South Korea Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Protein Chips Market Size in USD Million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.4.2. Africa Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.4.3. South America Protein Chips Market Size in USD Million (2021-2030)

8. Protein Chips Market Company and Product Profiles

• 8.1. Agilent Technologies, Inc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. RayBiotech, Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Sengenics Corporation LLC.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. CDI Labs.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Creative Biolabs
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Proteintech Group, Inc
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. RayBiotech Life Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. QUOTIENT LIMITED
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. PerkinElmer Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Merck KGAA
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Illmina Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Arrayit Corporation
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Spectrum Solutions
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. ACROBiosystems
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Sengenics Corporation LLC
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us